Principal Securities Inc. Makes New $2.44 Million Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Principal Securities Inc. acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 7,229 shares of the medical equipment provider's stock, valued at approximately $2,439,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its position in shares of Intuitive Surgical by 0.3% in the 4th quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 8,899 shares of the medical equipment provider's stock valued at $3,002,000 after buying an additional 27 shares in the last quarter. Liberty Capital Management Inc. increased its position in Intuitive Surgical by 3.8% during the 4th quarter. Liberty Capital Management Inc. now owns 815 shares of the medical equipment provider's stock worth $275,000 after purchasing an additional 30 shares in the last quarter. Miracle Mile Advisors LLC increased its position in Intuitive Surgical by 2.3% during the 4th quarter. Miracle Mile Advisors LLC now owns 1,438 shares of the medical equipment provider's stock worth $485,000 after purchasing an additional 32 shares in the last quarter. Ausdal Financial Partners Inc. increased its position in Intuitive Surgical by 1.5% during the 4th quarter. Ausdal Financial Partners Inc. now owns 2,192 shares of the medical equipment provider's stock worth $739,000 after purchasing an additional 33 shares in the last quarter. Finally, Venturi Wealth Management LLC increased its position in Intuitive Surgical by 10.7% during the 4th quarter. Venturi Wealth Management LLC now owns 341 shares of the medical equipment provider's stock worth $115,000 after purchasing an additional 33 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

ISRG traded up $1.25 during trading on Friday, reaching $386.70. 853,077 shares of the company traded hands, compared to its average volume of 1,470,012. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $403.76. The firm has a fifty day simple moving average of $385.21 and a 200 day simple moving average of $352.40. The company has a market cap of $137.17 billion, a P/E ratio of 69.80, a PEG ratio of 4.95 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating analysts' consensus estimates of $1.40 by $0.10. The business had revenue of $1.89 billion for the quarter, compared to analysts' expectations of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business's revenue was up 11.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.00 earnings per share. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. BTIG Research upped their price objective on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a "buy" rating in a research report on Friday, April 19th. Citigroup boosted their target price on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a "buy" rating in a report on Wednesday, April 3rd. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an "overweight" rating in a report on Friday, January 19th. Truist Financial boosted their target price on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a "buy" rating in a report on Wednesday, January 24th. Finally, Piper Sandler boosted their target price on shares of Intuitive Surgical from $425.00 to $435.00 and gave the stock an "overweight" rating in a report on Friday, April 19th. Five research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus price target of $396.17.

Insider Activity at Intuitive Surgical

In other news, SVP Mark Brosius sold 196 shares of the firm's stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total value of $78,400.00. Following the completion of the transaction, the senior vice president now directly owns 1,842 shares in the company, valued at $736,800. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, SVP Mark Brosius sold 196 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the transaction, the senior vice president now directly owns 1,842 shares in the company, valued at $736,800. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Marshall Mohr sold 108,790 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total value of $41,892,853.20. Following the transaction, the vice president now owns 26,877 shares of the company's stock, valued at $10,349,795.16. The disclosure for this sale can be found here. Insiders have sold a total of 147,927 shares of company stock valued at $57,064,459 over the last quarter. 0.80% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.